AbbVie Inc.
APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
Last updated:
Abstract:
Disclosed herein are compounds that inhibit the activity of anti-apoptotic Bc1-2 proteins, compositions containing the compounds and methods of treating diseases using the compounds.
Status:
Application
Type:
Utility
Filling date:
9 Dec 2019
Issue date:
22 Oct 2020